Rankings
▼
Calendar
EOLS Q4 2020 Earnings — Evolus, Inc. Revenue & Financial Results | Market Cap Arena
EOLS
Evolus, Inc.
$353M
Q4 2020 Earnings
Healthcare
Drug Manufacturers - Specialty & Generic
Income Statement
Revenue
$21M
+5.8% YoY
Gross Profit
$13M
64.6% margin
Operating Income
-$108M
-525.0% margin
Net Income
-$111M
-538.0% margin
EPS (Diluted)
$-3.28
QoQ Revenue Growth
+16.5%
Cash Flow
Operating Cash Flow
-$2M
Free Cash Flow
-$2M
Stock-Based Comp.
$3M
Balance Sheet
Total Assets
$209M
Total Liabilities
$282M
Stockholders' Equity
-$73M
Cash & Equivalents
$103M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$21M
$19M
+5.8%
Gross Profit
$13M
$14M
-7.3%
Operating Income
-$108M
-$16M
-560.3%
Net Income
-$111M
-$15M
-663.0%
Revenue Segments
Product
$21M
100%
← FY 2020
All Quarters
Q1 2021 →